Insys Therapeutics, Inc.
INSY
INSY was delisted on the 18th of June, 2019.
133 hedge funds and large institutions have $841M invested in Insys Therapeutics, Inc. in 2015 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 44 increasing their positions, 42 reducing their positions, and 14 closing their positions.
143% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 14
44% more capital invested
Capital invested by funds: $586M → $841M (+$255M)
34% more call options, than puts
Call options by funds: $7.25M | Put options by funds: $5.39M
18% more funds holding
Funds holding: 113 → 133 (+20)
5% more repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 42
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$20.3M |
| 2 |
TA
Teachers Advisors
New York
|
+$17.4M |
| 3 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$17.4M |
| 4 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
+$14.5M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$12.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$30.2M |
| 2 |
Millennium Management
New York
|
-$23.2M |
| 3 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
-$22.2M |
| 4 |
ECP
Empyrean Capital Partners
Los Angeles,
California
|
-$13.1M |
| 5 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$11.7M |
INSY Hedge Fund Activity: Q1 2015 in Review
133 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Insys Therapeutics, Inc. (INSY) for Q1 2015, worth a combined $841M — up 44% from $586M a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new INSY positions and 14 closed out — a net gain of 20 holders — while 44 added to existing stakes and 42 trimmed.
The largest buyer was State Street, adding an estimated $20.3M. The largest seller was Point72 Asset Management, cutting an estimated $30.2M.
- 133 institutional investors held Insys Therapeutics, Inc. (INSY) as of Q1 2015, up from 113 in Q4 2014.
- Funds reported $841M of Insys Therapeutics, Inc. stock for Q1 2015, up 44% quarter-over-quarter.
- 34 funds opened new Insys Therapeutics, Inc. positions in Q1 2015 and 14 closed out, a net change of +20 holders.
- The largest Insys Therapeutics, Inc. buyer in Q1 2015 was State Street, an estimated $20.3M added.
- The largest Insys Therapeutics, Inc. seller in Q1 2015 was Point72 Asset Management, an estimated $30.2M sold.
Based on aggregated 13F filings for Q1 2015.